Benefits From Small Molecule Administration as Compared With Abciximab Among Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Angioplasty: A Meta-Analysis

The aim of the study was to perform a meta-analysis of randomized trials (RTs) comparing abciximab versus small molecules (eptifibatide and tirofiban) in primary angioplasty (PPCI) for ST-segment elevation myocardial infarction (STEMI). Abciximab has been shown to provide significant benefits in PPC...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American College of Cardiology 2009-05, Vol.53 (18), p.1668-1673
Hauptverfasser:	DE LUCA, Giuseppe, UCCI, Grazia, CASSETTI, Ettore, MARINO, Paolo
Format:	Artikel
Sprache:	eng
Schlagworte:	Angioplasty Angioplasty, Balloon Antibodies, Monoclonal - therapeutic use Anticoagulants - therapeutic use Bias Biological and medical sciences Cardiology Cardiology. Vascular system Confidence Intervals Coronary Angiography Coronary heart disease Diseases of the cardiovascular system Drug dosages Fibrinolytic Agents - therapeutic use Heart Heart attacks Hematologic Agents - therapeutic use Humans Immunoglobulin Fab Fragments - therapeutic use Medical imaging Medical sciences Meta-analysis Mortality Myocardial Infarction - drug therapy Myocardial Infarction - mortality Myocardial Infarction - physiopathology Myocardial Infarction - therapy Myocarditis. Cardiomyopathies Odds Ratio Peptides - therapeutic use Platelet Aggregation Inhibitors - therapeutic use Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) Stents Studies Tyrosine - analogs & derivatives Tyrosine - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!